The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Turku University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Turku University Hospital
ClinicalTrials.gov Identifier:
NCT01484704
First received: November 30, 2011
Last updated: December 1, 2011
Last verified: November 2011
  Purpose

The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.


Condition
Mammary Ductal Carcinoma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Turku University Hospital:

Estimated Enrollment: 100
Study Start Date: February 2011
Groups/Cohorts
No treatment
MRI

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Newly diagnosted breast cancer patients

Criteria

Inclusion Criteria:

  • Tumor size less than 2cm
  • Ductal carcinoma unifocal

Exclusion Criteria:

  • Previous breast cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01484704

Contacts
Contact: Nina M Brück, MD +35823130544 nina.bruck@tyks.fi

Locations
Finland
University hospital of Turku Recruiting
Turku, Finland, 20521
Contact: Nina M Brück, MD       nina.bruck@tyks.fi   
Principal Investigator: Nina M Brück, MD         
Sponsors and Collaborators
Turku University Hospital
  More Information

No publications provided

Responsible Party: Turku University Hospital
ClinicalTrials.gov Identifier: NCT01484704     History of Changes
Other Study ID Numbers: 63/180/2010
Study First Received: November 30, 2011
Last Updated: December 1, 2011
Health Authority: Finland: Ethics Committee

Keywords provided by Turku University Hospital:
Carcinoma ductale mammae

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Neoplasms, Ductal, Lobular, and Medullary
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 20, 2014